Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
Agonists at the nicotinic acetylcholine alpha 7 receptor (nAChR α7) subtype have the potential to treat cognitive deficits in patients with Alzheimer's disease (AD) or schizophrenia. Visuo-spatial paired associates learning (vsPAL) is a task that has been shown to reliably predict conversion fr...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5736175?pdf=render |
_version_ | 1818541044291076096 |
---|---|
author | Michael R Weed Joseph Polino Laura Signor Mark Bookbinder Deborah Keavy Yulia Benitex Daniel G Morgan Dalton King John E Macor Robert Zaczek Richard Olson Linda J Bristow |
author_facet | Michael R Weed Joseph Polino Laura Signor Mark Bookbinder Deborah Keavy Yulia Benitex Daniel G Morgan Dalton King John E Macor Robert Zaczek Richard Olson Linda J Bristow |
author_sort | Michael R Weed |
collection | DOAJ |
description | Agonists at the nicotinic acetylcholine alpha 7 receptor (nAChR α7) subtype have the potential to treat cognitive deficits in patients with Alzheimer's disease (AD) or schizophrenia. Visuo-spatial paired associates learning (vsPAL) is a task that has been shown to reliably predict conversion from mild cognitive impairment to AD in humans and can also be performed by nonhuman primates. Reversal of scopolamine-induced impairment of vsPAL performance may represent a translational approach for the development of nAChR α7 agonists. The present study investigated the effect of treatment with the acetylcholinesterase inhibitor, donepezil, or three nAChR α7 agonists, BMS-933043, EVP-6124 and RG3487, on vsPAL performance in scopolamine-treated cynomolgus monkeys. Scopolamine administration impaired vsPAL performance accuracy in a dose- and difficulty- dependent manner. The impairment of eventual accuracy, a measure of visuo-spatial learning during the task, was significantly ameliorated by treatment with donepezil (0.3 mg/kg, i.m.), EVP-6124 (0.01 mg/kg, i.m.) or BMS-933043 (0.03, 0.1 and 0.3 mg/kg, i.m.). Both nAChR α7 agonists showed inverted-U shaped dose-effect relationships with EVP-6124 effective at a single dose only whereas BMS-933043 was effective across at least a 10 fold dose/exposure range. RG3487 was not efficacious in this paradigm at the dose range examined (0.03-1 mg/kg, i.m.). These results are the first demonstration that the nAChR α7 agonists, EVP-6124 and BMS-933043, can ameliorate scopolamine-induced cognitive deficits in nonhuman primates performing the vsPAL task. |
first_indexed | 2024-12-11T22:03:23Z |
format | Article |
id | doaj.art-7092e6186ae346de8340928c86171e4b |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-11T22:03:23Z |
publishDate | 2017-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-7092e6186ae346de8340928c86171e4b2022-12-22T00:49:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011212e018760910.1371/journal.pone.0187609Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.Michael R WeedJoseph PolinoLaura SignorMark BookbinderDeborah KeavyYulia BenitexDaniel G MorganDalton KingJohn E MacorRobert ZaczekRichard OlsonLinda J BristowAgonists at the nicotinic acetylcholine alpha 7 receptor (nAChR α7) subtype have the potential to treat cognitive deficits in patients with Alzheimer's disease (AD) or schizophrenia. Visuo-spatial paired associates learning (vsPAL) is a task that has been shown to reliably predict conversion from mild cognitive impairment to AD in humans and can also be performed by nonhuman primates. Reversal of scopolamine-induced impairment of vsPAL performance may represent a translational approach for the development of nAChR α7 agonists. The present study investigated the effect of treatment with the acetylcholinesterase inhibitor, donepezil, or three nAChR α7 agonists, BMS-933043, EVP-6124 and RG3487, on vsPAL performance in scopolamine-treated cynomolgus monkeys. Scopolamine administration impaired vsPAL performance accuracy in a dose- and difficulty- dependent manner. The impairment of eventual accuracy, a measure of visuo-spatial learning during the task, was significantly ameliorated by treatment with donepezil (0.3 mg/kg, i.m.), EVP-6124 (0.01 mg/kg, i.m.) or BMS-933043 (0.03, 0.1 and 0.3 mg/kg, i.m.). Both nAChR α7 agonists showed inverted-U shaped dose-effect relationships with EVP-6124 effective at a single dose only whereas BMS-933043 was effective across at least a 10 fold dose/exposure range. RG3487 was not efficacious in this paradigm at the dose range examined (0.03-1 mg/kg, i.m.). These results are the first demonstration that the nAChR α7 agonists, EVP-6124 and BMS-933043, can ameliorate scopolamine-induced cognitive deficits in nonhuman primates performing the vsPAL task.http://europepmc.org/articles/PMC5736175?pdf=render |
spellingShingle | Michael R Weed Joseph Polino Laura Signor Mark Bookbinder Deborah Keavy Yulia Benitex Daniel G Morgan Dalton King John E Macor Robert Zaczek Richard Olson Linda J Bristow Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning. PLoS ONE |
title | Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning. |
title_full | Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning. |
title_fullStr | Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning. |
title_full_unstemmed | Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning. |
title_short | Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning. |
title_sort | nicotinic alpha 7 receptor agonists evp 6124 and bms 933043 attenuate scopolamine induced deficits in visuo spatial paired associates learning |
url | http://europepmc.org/articles/PMC5736175?pdf=render |
work_keys_str_mv | AT michaelrweed nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning AT josephpolino nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning AT laurasignor nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning AT markbookbinder nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning AT deborahkeavy nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning AT yuliabenitex nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning AT danielgmorgan nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning AT daltonking nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning AT johnemacor nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning AT robertzaczek nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning AT richardolson nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning AT lindajbristow nicotinicalpha7receptoragonistsevp6124andbms933043attenuatescopolamineinduceddeficitsinvisuospatialpairedassociateslearning |